Business Wire
24 Aug 2026, 13:47 UTC · 2h ago
QIAGEN Appoints Jonathan M. Pratt as Chief Executive Officer
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
Business Wire
24 Aug 2026, 13:47 UTC · 2h ago
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
What the story claims
1 claim · each scored for market impact
QIAGEN has appointed Jonathan M. Pratt as Chief Executive Officer, effective September 1, 2026. — CEO transitions are material, but the extremely long lead time (over two years) minimizes immediate market volatility.
+0.10Which stocks this story touches
The appointment of a highly experienced CEO from the life sciences and healthcare sector is generally positive.
The company is mentioned only as the acquirer of Filtration Group in a historical context.
Continue reading
6 related stories
Search tags
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
Proactive Investors
3h ago
